Table 1 Characteristics of participants (N = 56) and the comparison of ACE2 expression of AMs between subgroups.
Characteristic | Number (%) | Mean (SD) ACE2a | P-valueb |
---|---|---|---|
Age (years) | |||
  > 65 | 25 (44.6) | 12.04 (1.25) | 0.387 |
  ≤ 65 | 31 (55.4) | 11.77 (1.10) | |
Sex | |||
 Male | 41 (73.2) | 11.94 (1.15) | 0.580 |
 Female | 15 (26.8) | 11.74 (1.22) | |
Overweight | |||
 BMI ≥ 24 | 25 (44.6) | 11.71 (1.27) | 0.310 |
 BMI < 24 | 31 (55.4) | 12.03 (1.07) | |
Smoking status | |||
 Current smoker | 22 (39.3) | 12.29 (1.01) | 0.037 |
 Not current smoker | 34 (60.7) | 11.63 (1.20) | |
COPD | |||
 Yes | 22 (39.3) | 12.18 (1.22) | 0.126 |
 No | 34 (60.7) | 11.70 (1.10) | |
Lung cancer | |||
 Yes | 30 (53.6) | 11.84 (1.20) | 0.757 |
 No | 26 (46.4) | 11.94 (1.14) | |
CVD | |||
 Yes | 21 (37.5) | 11.71 (0.86) | 0.333 |
 No | 35 (62.5) | 11.99 (1.31) | |
DM | |||
 Yes | 10 (17.9) | 11.74 (1.11) | 0.657 |
 No | 46 (82.1) | 11.92 (1.18) | |
RAAS inhibitor use | |||
 Yes | 5 (8.9) | 12.10 (1.40) | 0.673 |
 No | 51 (90.1) | 11.87 (1.15) |